• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
37.0210703
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
220.39
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Puravankara bags Rs 60-cr order for Westin Hotel project in Bengaluru
May 13,2026

The project is located at Survey Nos. 12 and 13, near Kundalahalli Metro Station in EPIP Area, Whitefield, Bengaluru.

The contract is an item-rate agreement with an estimated value of Rs 57.80 crore, excluding applicable taxes, duties and levies. The project is scheduled to be executed over a period of 20 months.

The company said the order has been awarded by a domestic entity and does not involve any related party transaction or promoter group interest.

Puravankara is engaged in the business of real estate development.

The company reported a consolidated net profit of Rs 59.34 crore in Q3 FY26 as a net loss of Rs 93.16 crore in Q3 FY25. Revenue from operations zoomed 236.1% year on year to Rs 1,069.31 crore in Q3 FY26.

Shares of Puravankara rose 0.12% to Rs 211.85 on the BSE.